Acurx Pharmaceuticals, Inc. Share Price
ACXPAcurx Pharmaceuticals, Inc. Stock Performance
Open $5.33 | Prev. Close $5.20 | Circuit Range N/A |
Day Range $5.31 - $7.50 | Year Range $1.37 - $21.00 | Volume 47,817 |
Average Traded $6.73 |
Acurx Pharmaceuticals, Inc. Share Price Chart
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Acurx Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
18-Mar-26 | $4.46 | $5.24 | +6.51% |
17-Mar-26 | $4.83 | $4.92 | +2.18% |
16-Mar-26 | $4.24 | $4.81 | +20.85% |
13-Mar-26 | $4.11 | $3.98 | -20.56% |
12-Mar-26 | $5.00 | $5.01 | -16.71% |
11-Mar-26 | $3.48 | $6.01 | +105.29% |
10-Mar-26 | $2.12 | $2.93 | +46.50% |